Seelos Announces Second Postponement of its Annual Meeting of Stockholders
Hand-out
Press Releases
October 24, 2024

Seelos Announces Second Postponement of its Annual Meeting of Stockholders

NEW YORK, Oct. 24, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (OTCQB: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare

bradford

The Bradford Era

Local & Social